Cargando…

Loss of Asthma Control in Pediatric Patients after Discontinuation of Long-Acting Beta-Agonists

Recent asthma recommendations advocate the use of long-acting beta-agonists (LABAs) in uncontrolled asthma, but also stress the importance of stepping down this therapy once asthma control has been achieved. The objective of this study was to evaluate downtitration of LABA therapy in pediatric patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	R. O'Hagan, Adrian, Morton, Ronald, Eid, Nemr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432548/ https://www.ncbi.nlm.nih.gov/pubmed/22966431 http://dx.doi.org/10.1155/2012/894063

Ejemplares similares

Anti-inflammatory dosing of theophylline in the treatment of status asthmaticus in children
por: Eid, Nemr S, et al.
Publicado: (2016)

Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
por: Dreher, Michael, et al.
Publicado: (2018)

Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome
por: Lee, Suh-Young, et al.
Publicado: (2016)

RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
por: Postma, Dirkje S., et al.
Publicado: (2008)

Retraction Note to: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?
por: Postma, Dirkje S., et al.
Publicado: (2009)

The benefits of combined treatment with corticosteroids and long-acting beta agonists
por: Singh, Dave
Publicado: (2006)

Long-Acting Beta Agonists Enhance Allergic Airway Disease
por: Knight, John M., et al.
Publicado: (2015)

Real-Life Patterns of Exacerbations While on Inhaled Corticosteroids and Long-Acting Beta Agonists for Asthma over 15 Years
por: McGeachie, Michael J., et al.
Publicado: (2020)

Symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for adult patients with asthma who are non-adherent to daily maintenance inhalers: a study protocol for a pragmatic randomized controlled trial
por: Krings, James G., et al.
Publicado: (2022)

Applying the Risk of Bias Tool in a Systematic Review of Combination Long-Acting Beta-Agonists and Inhaled Corticosteroids for Persistent Asthma
por: Hartling, Lisa, et al.
Publicado: (2011)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
por: Scichilone, Nicola, et al.
Publicado: (2014)

Placebo-Controlled Discontinuation of Long-Term Acid-Suppressant Therapy: A Randomised Trial in General Practice
por: Zwisler, Jon Eik, et al.
Publicado: (2015)

Paradoxical Bronchoconstriction with Short-Acting Beta Agonist
por: Magee, Jared S., et al.
Publicado: (2018)

Effect of Traditional Chinese Medicine on Inflammatory Mediators in Pediatric Asthma
por: Du, Hui, et al.
Publicado: (2016)

Factors Associated with Failure of Intermittent Nebulization with Short-Acting Beta-Agonists in Children with Severe Asthma Exacerbation
por: Kulalert, Prapasri, et al.
Publicado: (2020)

Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma
por: Kaye, Leanne, et al.
Publicado: (2022)

Prediction of short-acting beta-agonist usage in patients with asthma using temporal-convolutional neural networks
por: Hirons, Nicholas, et al.
Publicado: (2023)

Association between ADAM33 Single-Nucleotide Polymorphisms and Treatment Response to Inhaled Corticosteroids and a Long-Acting Beta-Agonist in Asthma
por: Vishweswaraiah, Sangeetha, et al.
Publicado: (2023)

Hydroxychloroquine concentrations persist after drug discontinuation
Publicado: (2022)

Haloperidol decanoate long-acting injection (HDLAI): Results of a 1-year mirror-image study
por: Mace, Shubhra, et al.
Publicado: (2018)

Phosphodiesterase Type 4D Gene Polymorphism: Association with the Response to Short-Acting Bronchodilators in Paediatric Asthma Patients
por: Labuda, Malgorzata, et al.
Publicado: (2011)

Comparison of vilanterol, a novel long-acting beta(2) agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
por: Lötvall, Jan, et al.
Publicado: (2014)

Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany
por: Worth, Heinrich, et al.
Publicado: (2021)

Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study
por: Lee, Hyun, et al.
Publicado: (2021)

Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist
por: Beeh, Kai M, et al.
Publicado: (2010)

Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
por: Rottenkolber, Marietta, et al.
Publicado: (2015)

Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD
por: Jabbal, Sunny, et al.
Publicado: (2017)

Is Anticoagulation Discontinuation Achievable with Citrate Dialysate during HDF Sessions?
por: Dolley-Hitze, Thibault, et al.
Publicado: (2016)

The association between seasonal asthma exacerbations and viral respiratory infections in a pediatric population receiving inhaled corticosteroid therapy with or without long-acting beta-adrenoceptor agonist: A randomized study()
por: Prazma, Charlene M., et al.
Publicado: (2015)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
por: Tehraninejad, Ensieh Sh., et al.
Publicado: (2010)

Pulmonary Function Tests in Emergency Department Pediatric Patients with Acute Wheezing/Asthma Exacerbation
por: Giordano, Kathryn, et al.
Publicado: (2012)

Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension
por: Cui, Pei-Jing, et al.
Publicado: (2017)

Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β(2)-agonists in patients with atopic asthma
por: Bateman, Eric D, et al.
Publicado: (2018)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
por: Lee, Eung Gu, et al.
Publicado: (2023)

Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial
por: Haney, Sarah, et al.
Publicado: (2005)

Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
por: Tashkin, Donald P, et al.
Publicado: (2010)

Genome‐wide association studies of exacerbations in children using long‐acting beta2‐agonists
por: Slob, Elise M. A., et al.
Publicado: (2021)

Oral enoximone allows the reduction and discontinuation of inhaled steroids and beta2 agonists in asthmatic children
por: Beute, Jan, et al.
Publicado: (2022)

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis
por: Eisen, T, et al.
Publicado: (2006)

Predicting the Long-Term Course of Asthma in Wheezing Infants Is Still a Challenge
por: Amat, Flore, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4ek52nd50kavknan037j0f9g82